SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Chemo Pharma Labs - Quaterly Results

20 Oct 2022 Evaluate
The revenue slipped marginally during the September 2022 quarter. A decline of about Rs. 0.00 millions was observed as compared to Rs. 0.00 millions during the corresponding quarter last year.Net Profit witnessed a 377.68% growth almost the double from Rs. 1.12 millions to Rs. 5.35  millions  of same quarter last year.OP of the company witnessed a marginal growth to 5.36 millions from 1.21 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 5.90 1.90 210.53 2.05 2.99 -31.44 7.89 6.68 18.11
PBIDT 5.36 1.21 342.98 0.38 1.52 -75.00 3.84 3.35 14.63
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 5.36 1.21 342.98 0.38 1.52 -75.00 3.84 3.35 14.63
Depreciation 0.03 0.09 -66.67 0.06 0.09 -33.33 0.19 0.24 -20.83
PBT 5.33 1.12 375.89 0.32 1.43 -77.62 3.65 3.11 17.36
TAX -0.02 0.00 0.00 -0.02 0.00 0.00 -1.96 0.60 -426.67
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.30 0.00 0.00
PAT 5.35 1.12 377.68 0.34 1.43 -76.22 5.61 2.51 123.51
Equity 15.00 15.00 0.00 15.00 15.00 0.00 15.00 15.00 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Starsource Multitrad Share Price

116.50 -6.10 (-4.98%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×